| Literature DB >> 35089533 |
Charlotte Goldfine1, Derrick Lung2, Gillian Beauchamp3, Ayrn O'Connor4, Andrew Stolbach5, Louise Kao6, Bryan Judge7, Paul Wax8, Rahul Patwari9, Ziad Kazzi10.
Abstract
BACKGROUND: Currently, no standardized core content in medical toxicology exists for medical students. The goals of this study were to (1) assess the current state and needs of medical toxicology clerkships and (2) develop a consensus-derived list of core topics that should be covered during a medical toxicology clerkship.Entities:
Keywords: Core content; Medical education; Medical toxicology
Mesh:
Year: 2022 PMID: 35089533 PMCID: PMC8796743 DOI: 10.1007/s13181-021-00874-z
Source DB: PubMed Journal: J Med Toxicol ISSN: 1556-9039
Proposed medical toxicology clerkship core content
| Tier 1 | 1.1 Pharmacology/toxicology 1.2 Drugs 1.3 Drugs of abuse 1.4 Natural products 1.5 Pharmacological basis of antidote use 1.6 Toxicologic syndromes 1.7 Vital sign abnormalities 1.8 Initial management 1.9 Supportive and other care 1.10 Withdrawal syndrome management 1.11 Industrial, household, and environmental toxins 1.12 Differential diagnosis by clinical findings 1.13 ABCs-resuscitation |
| Tier 2 | 2.1 Poison centers 2.2 Laboratory and other diagnostic assessments 2.3 Mechanisms of reproductive and developmental toxicity 2.4 Pediatric and reproductive syndromes (developmental disorders, teratogenesis) 2.5 Radiation syndromes 2.6 Toxic outbreaks of historical significance (e.g., Yusho, toxic oil) 2.7 Response to hazardous materials (Hazmat) incidents, including terrorism 2.8 Warfare and terrorism 2.9 Molecular components/mechanisms 2.10 Assay methods and interpretation |
| 1.1 Pharmacology/toxicology |
|---|
| 1.2 Molecular components/mechanisms |
| 1.3 Cytotoxic mechanisms (e.g., apoptosis, microtubular dysfunction) |
| 1.4 Principles of radiation (e.g., decay, units) |
| 1.5 Mutagenesis and carcinogenesis |
| 1.6 Mechanisms of reproductive and developmental toxicity |
| 2.1 Drugs (pharmaceuticals) |
| 2.2 Drugs of abuse |
| 2.3 Industrial, household, and environmental toxicants |
| 2.4 Natural products (e.g., plants, envenomations) |
| 2.5 Warfare and terrorism |
| 2.6 Radiological |
| 3.1 Toxicologic syndromes (e.g., cholinergic, opioid) |
| 3.2 Vital sign abnormalities/syndromes |
| 3.3 Differential diagnosis by clinical finding |
| 3.4 Pediatric and reproductive syndromes (developmental disorders, teratogenesis) |
| 3.5 Radiation syndromes |
| 3.6 Syndromes attributed to the environment, not specified elsewhere (e.g., mold, multiple chemical sensitivity) |
| 3.7 Toxic outbreaks of historical significance (e.g., Yusho, toxic oil) |
| 4.1 ABCs-resuscitation |
| 4.2 Initial management |
| 4.3 Pharmacological basis of antidote use |
| 4.4 Supportive and other care |
| 4.5 Withdrawal syndrome management |
| 4.6 Radiation exposure management (e.g., triage, medical therapy) |
| 5.1 Criteria for causal inference (e.g., biological plausibility, consistency, dose–response relationship, strength of association, temporal relationship) |
| 5.2 Monitoring |
| 5.3 Occupational assessment and prevention |
| 5.4 Principles of epidemiology and study design |
| 5.5 Risk assessment and management |
| 5.6 Poison centers |
| 5.7 Response to hazardous materials (Hazmat) incidents, including terrorism |
| 5.8 Role of federal and international agencies in toxicology |
| 5.9 Injury prevention |
| 5.10 Medical publishing |
| 5.11 Consultation resources (e.g., databases, National Library of Medicine) |
| 6.1 Assay methods and interpretation |
| 6.2 Detection and interpretation of performance enhancing substances |
| 6.3 Laboratory and other diagnostic assessments |
| 6.4 Forensics |
| 6.5 Legal drugs of abuse (e.g., psychomotor impairment) |
| 6.6 Legal ethanol (e.g., legal aspects of alcohol use) |
| 6.7 Medical legal issues |
| Other (please specify) |